"Welcome to SSJ Finance"

Profit & Loss Accounts

Key Financial Ratios

Ajanta Pharma Ltd
Industry : Pharmaceuticals - Indian - Formulations	Chairman : Mannalal B Agrawal
Home : Indian Private	Book Value: 290.1676063
BSE Code : 532331	Market Cap: 30786.01
NSE Code : AJANTPHARM	P / E : 32.9

Change Company :

(Rs in Cr.)

Key Finacial Ratios

Years	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Debt-Equity Ratio	0.01	0.01	0.01	0.01	0.01
Long Term Debt-Equity Ratio	0.01	0.01	0.01	0.01	0.01
Current Ratio	2.65	2.33	2.46	3.03	2.62
Fixed Assets	1.69	1.73	1.55	1.48	1.35
Inventory	6.10	5.83	5.17	4.95	5.08
Debtors	3.55	3.63	3.38	3.44	3.59
Interest Cover Ratio	257.53	162.32	134.81	99.74	131.74
PBIDTM (%)	30.65	31.12	24.39	32.82	37.54
PBITM (%)	27.41	27.79	20.67	28.96	33.44
PBDTM (%)	30.54	30.95	24.24	32.53	37.28
CPM (%)	24.45	23.66	20.10	26.77	28.95
APATM (%)	21.21	20.33	16.38	22.92	24.85
ROCE (%)	32.78	32.49	21.63	29.60	33.43
RONW (%)	26.05	24.24	17.42	23.78	25.28

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView